• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Clearer Path to Weight Management: The Ozempic Factor

    Under Pressure: Stress and Mental Health Have Taken Center Stage

    Sustainable Business Development: Principles and Strategies for Progress

    Beauty IO MarketWatch: L’Oréal to Define the Next Era of Beauty Tech in CES 2024 Keynote

    Introducing the Happi & Nutraceuticals World Wellness Conference & Tabletop Exhibition
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Releases Sustainability Report for Omega-3s Industry

    ABC’s Journal HerbalGram Celebrates 40th Anniversary

    Curcumin May Be As Effective as PPI for Indigestion

    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies

    Women in Nutraceuticals Launches Pilot Mentorship Program
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Releases Sustainability Report for Omega-3s Industry

    ABC’s Journal HerbalGram Celebrates 40th Anniversary

    Curcumin May Be As Effective as PPI for Indigestion

    Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander

    Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    GOED Releases Sustainability Report for Omega-3s Industry

    ABC’s Journal HerbalGram Celebrates 40th Anniversary

    Curcumin May Be As Effective as PPI for Indigestion

    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies

    Women in Nutraceuticals Launches Pilot Mentorship Program
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Curcumin May Be As Effective as PPI for Indigestion

    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies

    Weight Loss Products Sold as Supplements Adulterated with Toxic Yellow Oleander

    Nature’s Way Canada Launches NutraSea Omega-3 Kids Chews

    Kyowa Hakko's Immuse Postbiotic Introduced to Mexican Market
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    BGG World

    Premium Labels & Packaging Solutions

    Bioenergy Life Science, Inc. (BLS)

    JRS Pharma

    Aiya America, Inc. (Aiya Matcha)
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    BGG World

    Premium Labels & Packaging Solutions

    Bioenergy Life Science, Inc. (BLS)

    JRS Pharma

    Aiya America, Inc. (Aiya Matcha)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    FDA Plans to Modernize Dietary Supplement Regulations

    Agency seeks to balance consumer access to safe, lawful products while promoting industry innovation.

    FDA Plans to Modernize Dietary Supplement Regulations
    By Sean Moloughney, Editor02.12.19
    The U.S. Food and Drug Administration will embark on a plan to implement “one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years,” according to FDA Commissioner Scott Gottlieb, MD, who laid out the agency’s goals and priorities in a statement on Feb. 11.
     
    Gottlieb noted significant industry growth since the passage of the landmark Dietary Supplement Health and Education Act (DSHEA) of 1994, which established the industry’s current regulatory framework.
     
    “I’m concerned that changes in the supplement market may have outpaced the evolution of our own policies and our capacity to manage emerging risks,” Gottlieb said. “To continue to fulfill our public health obligations we need to modernize and strengthen our overall approach to these products.”
     
    At the same time the agency announced it sent 12 warning letters and five online advisory letters to companies whose products—many of which are marketed as dietary supplements—are being sold illegally as unapproved new drugs because they make unproven claims to prevent, treat, or cure Alzheimer’s disease or other diseases and conditions like diabetes and cancer.
     
    Agency Goals, Priorities & Potential Actions
    Gottlieb noted the agency’s top priorities for dietary supplements include ensuring safety; maintaining product integrity (confirming that supplements contain what the label claims and that products are manufactured according to quality standards); as well as ensuring that consumers and healthcare professionals are able to make informed decisions before recommending, purchasing, or using dietary supplements.
     
    Among the steps the agency is considering or actively formulating, include:
     
    1) Establish new ways to communicate concerns that an ingredient is unlawful and potentially dangerous. “We’re developing a new rapid-response tool to alert the public so consumers can avoid buying or using products with that ingredient, and to notify responsible industry participants to avoid making or selling them,” Gottlieb said.
     
    2) The agency’s regulatory framework must be flexible enough to evaluate product safety adequately while promoting innovation. “The key to this effort will be important steps to foster the submission of new dietary ingredient (NDI) notifications,” he said. “An effective NDI notification process represents the FDA’s only opportunity to evaluate the safety of a new ingredient before it becomes available to consumers and helps promote transparency and risk-based allocation of resources. We’re continuing to develop guidance for preparing NDI notifications to ensure FDA can thoroughly review the safety of these ingredients. In conjunction with this effort, we’re planning to update our compliance policy regarding NDIs.”
     
    The agency is planning a public meeting this spring on the topic of responsible innovation in the dietary supplement industry. Other challenges that may act as barriers to dietary supplement innovation and safety include what the right incentives might be for establishing dietary supplement exclusivity, and the scope of permitted dietary ingredients.
     
    “We invite all our stakeholders to share their views on how the FDA should strengthen the dietary supplement program for the future. So, please stay tuned for more information regarding registration and logistics,” Gottlieb said.
     
    3) Work closely with industry partners to protect public health and safety. As industry develops new products, ingredients, delivery systems, etc., Gottlieb said FDA must do more to leverage its resources and authorities to evaluate these products. “This requires collaborative research and a shared understanding. I’m pleased to announce that we’ve recently created the Botanical Safety Consortium, a public-private partnership that will gather leading scientific minds from industry, academia and government to promote scientific advances in evaluating the safety of botanical ingredients and mixtures in dietary supplements. This group will look at novel ways to use cutting-edge toxicology tools, including alternatives to animal testing, to promote the goals of safety and effectiveness we share with consumers and other stakeholders.”
     
    4) Continue taking actions to protect public health and develop new enforcement strategies. “We’re already making our internal processes more efficient for taking enforcement action when products claiming to be supplements contain unlawful ingredients, including drug ingredients,” said Gottlieb.
     
    5) Engage in a public dialogue about whether additional steps to modernize DSHEA are necessary. “We’ve heard from stakeholders who want to open such a dialogue,” Gottlieb noted. “While the FDA is committed to leveraging its existing resources and authorities to the fullest extent possible, we believe there may be value in a broader public conversation about whether certain changes to the law might be helpful. We believe there may be opportunities to modernize DSHEA for the future, while preserving the law’s essential balance.”
     
    For example, he noted some stakeholders have suggested establishing avenues for dietary supplement exclusivity and adding a product listing requirement, effectively improving transparency in the marketplace and promoting risk-based regulation. “It could also help facilitate efficient enforcement of the law and establish new mechanisms to identify bad actors who put the public at risk and undermine consumer confidence in the entire industry.”
     
    The agency will be sharing additional details in the coming months about steps to implement these priorities.
     
    The Balancing Act
    Looking at the big picture, Gottlieb expressed his belief that supplements have a role to play in supporting health, and acknowledged the agency must balance access to safe products from responsible companies while protecting consumers from dangerous and illegal products masquerading as supplements.
     
    “I’ve personally benefited from the use of dietary supplements and, as a physician, recognize the benefits of certain supplements as a part of a comprehensive care plan. It’s clear to me that dietary supplements play an important role in our lives as we strive to stay healthy. It’s also clear that the U.S. Food and Drug Administration plays an important role in helping consumers make use of safe, high-quality dietary supplements while also protecting Americans from the potential dangers of products that don’t meet the agency’s standards for marketing.”
     
    Toward that end, the agency sent 12 warning letters and five online advisory letters to companies whose products are being sold illegally as unapproved new drugs because they make unproven claims to prevent, treat, or cure Alzheimer’s disease or other diseases and conditions like diabetes and cancer.
     
    “Such claims can harm patients by discouraging them from seeking FDA-approved medical products that have been demonstrated to be safe and effective for these medical conditions,” said Gottlieb. “In recent years, we’ve also taken action against companies and dietary supplements making similar claims regarding treatment of serious conditions such as cancer and opioid addiction. These enforcement actions are just one part of our overall efforts to update our policy framework governing dietary supplements.”
     
    In December of last year FDA established a Dietary Supplement Working Group comprised of representatives from multiple centers and offices across the agency. The group is tasked with evaluating organizational structures, processes, procedures, and practices in order to identify opportunities to modernize oversight of dietary supplements.
     
    Industry Response
    Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN), said the association appreciates Gottlieb’s commitment to strengthen the dietary supplement industry and to modernize FDA’s oversight. “He clearly shares our respect, both as a doctor and as a consumer, for the power of dietary supplements to improve the lives and health of all Americans, three-quarters of whom already take our products each year. His statement shares our vision to further develop the thriving, innovative and safe marketplace for dietary supplements that, as he so eloquently states, play an important role as ‘we strive to stay healthy,’ and have ‘become a routine part of the American lifestyle.’”
     
    Mister also applauded the commissioner’s enthusiasm for rooting out bad actors who put consumers at risk, and commended enforcement actions to address this problem. “In conjunction with numerous innovative industry initiatives, CRN regularly calls out bad actors, bad ingredients, and bad products masquerading as dietary supplements. We welcome additional enforcement actions to bring to justice those who would cynically trade on the halo effect of responsible industry to make a quick buck while ignoring the safety and health of consumers.”
     
    He also called on Congress to appropriate adequate funds for FDA and other federal agencies to follow through on tough law enforcement.
     
    Additionally, CRN urged FDA to consider several matters, including:
     
    • Achieving clarity on an approved list of pre-DSHEA dietary ingredients;
    • Releasing final NDI Guidance that offers protection for innovation and research;
    • Furthering the global marketplace through predictable and consistent issuance of certificates of free sale for products at export; and,
    • Clarifying the legal path to market for hemp-derived cannabidiol (CBD) as a food and as a dietary supplement.
     
    In a memo to membership, United Natural Products Alliance (UNPA) President Loren Israelsen noted the FDA announcement falls on the 25th anniversary of DSHEA. “We recognize that the world has changed. We will work closely with FDA on each of the stated objectives and the new ideas they propose, and to participate actively in the dietary supplement working group, once that becomes more public, as well as the Botanical Safety Consortium. The prospect of amendments to DSHEA has long been discussed as a non-starter. We, of course, will listen closely to FDA's ideas regarding DSHEA amendments and will work in close consultation with our members to that end.”

    American Herbal Products Association (AHPA) President Michael McGuffin said AHPA shares the agency’s vision of “finding the right balance between preserving consumers’ access to lawful supplements, while also protecting the public from unsafe and unlawful products and holding accountable companies that are not in compliance with the law. AHPA has previously communicated specific suggestions for regulatory improvements to FDA and we look forward to a robust and transparent discussion on how best to serve Americans who include supplement products in their families’ healthcare choices.
     
    “AHPA has invested significant resources to assist industry in submitting NDI notifications that meet the statutory requirements to bring a new ingredient to market,” he continued. “We have also submitted thoughtful comments to FDA’s prior draft NDI guidance documents and will continue to provide input so that any eventual guidance is both useful to the trade and does not stray from FDA’s statutory authority.”
     
    AHPA’s Board of Trustees adopted a policy last November stating the current regulatory framework for supplements supports industry and consumers while providing FDA with adequate authority to regulate lawful products; and that regulations don’t need to be revised to mandate premarket registration or notification, McGuffin noted.
     
    “Any reconsideration of this position on a dietary supplement product listing regime would depend on whether the legislative package also includes provisions that appropriately reduce burdens on the industry or create new opportunities for it and the consumers it serves, for example in the context of nutrient content claims,” McGuffin said.
     
    Daniel Fabricant, PhD, president and CEO of the Natural Products Association (NPA), said the association looks forward to working with FDA on modernization, “but what consumers need is action. We encourage the FDA to use the current tools it has at its disposal to protect consumers from companies selling illegal products masquerading as nutritional supplements. The U.S. has the safest nutritional supplements in the world because of collaborative efforts between our industry and federal regulators, and we are confident that collaboration will continue.”
    Related Searches
    • Testing
    • Health
    • Research
    • Regulatory
    Related Knowledge Center
    • Regulations
    • Dietary Supplements
    • Quality & Safety
    Suggested For You
    Council for Responsible Nutrition (CRN) Council for Responsible Nutrition (CRN)
    FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease
    AHPA Revises Hemp-CBD Status Report AHPA Revises Hemp-CBD Status Report
    Conference Chairs Named for 2019 Legal, Regulatory & Compliance Forum on Dietary Supplements Conference Chairs Named for 2019 Legal, Regulatory & Compliance Forum on Dietary Supplements
    CRN Unveils New Chairman, 2019 Board of Directors CRN Unveils New Chairman, 2019 Board of Directors
    2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD 2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD
    Vitamins & Minerals: Traditions in Preventive Health Vitamins & Minerals: Traditions in Preventive Health
    FDA Launches Dietary Supplement Working Group FDA Launches Dietary Supplement Working Group
    Getting Ahead of the Curve: Consumers Seeking Specialty Nutritionals Getting Ahead of the Curve: Consumers Seeking Specialty Nutritionals
    CRN Survey Reaffirms Trust and Confidence in Dietary Supplement Industry CRN Survey Reaffirms Trust and Confidence in Dietary Supplement Industry
    JAMA Study Uncovers Unapproved Ingredients in Products Marketed as Dietary Supplements JAMA Study Uncovers Unapproved Ingredients in Products Marketed as Dietary Supplements
    Getting Ahead of the Curve: Natural OTCs Getting Ahead of the Curve: Natural OTCs
    Harvard Researcher Questions Probiotic Benefits Harvard Researcher Questions Probiotic Benefits
    MarketWatch 2018 MarketWatch 2018

    Related Buyers Guide Companies

    • Council for Responsible Nutrition (CRN)

      ...
      Gretchen Powers, VP Marketing & Member Experience 11.03.22

    • Breaking News | Dietary Supplements | Quality & Safety | Regulations | Regulatory News
      FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease

      FDA Cracks Down on Products Claiming to Treat Alzheimer’s Disease

      Failure to correct violations may result in legal action, including product seizure and/or injunction.
      02.12.19

    • Breaking News | Herbs & Botanicals | Industry & Market News | Regulations | Regulatory News
      AHPA Revises Hemp-CBD Status Report

      AHPA Revises Hemp-CBD Status Report

      The new draft addresses the recent FDA statement on hemp, CBD, and the 2018 Farm Bill; as well as state and tribal authority.
      02.01.19


    • Breaking News | Regulations | Regulatory News

      Conference Chairs Named for 2019 Legal, Regulatory & Compliance Forum on Dietary Supplements

      Event attracts in-house and outside counsel, regulatory compliance personnel, QC specialists, and government relations professionals.
      01.28.19

    • Breaking News | People News

      CRN Unveils New Chairman, 2019 Board of Directors

      Chairman named officers and committee chairs.
      01.18.19

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Todd Spear Joins Protein Research As VP Of Sales And Marketing
    • New Technology Converts Sugar In Juice To Fiber
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • HMB And Vitamin D Supplementation Linked To Reduction In Fat Stores
    Breaking News
    • GOED Releases Sustainability Report for Omega-3s Industry
    • ABC’s Journal HerbalGram Celebrates 40th Anniversary
    • Curcumin May Be As Effective as PPI for Indigestion
    • Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    • Women in Nutraceuticals Launches Pilot Mentorship Program
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • A Clearer Path to Weight Management: The Ozempic Factor
    • Under Pressure: Stress and Mental Health Have Taken Center Stage
    • Sustainable Business Development: Principles and Strategies for Progress
    • BIOHM Health Targets ‘Digestive Plaque’ with Probiotic, Fungus, and Enzyme Formula
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Releases Sustainability Report for Omega-3s Industry
    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Coatings World

    Latest Breaking News From Coatings World

    ACS Reports Chameleon Inspired Building Coating
    Substrate Wetting Agent Available from BRB International
    Nouryon Manufacturing Network Transitions to 100% Electricity From Renewable Sources in Brazil
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 23
    Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    FDA Clears MeMed BV Direct From Whole Blood
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Eftilagimod Cleared for Clinical Trial Use in the UK
    Veranova Names William Sanders Global VP of Chemical Development Ops
    Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Hailey Bieber's Rhode Expands Into Makeup
    Avon Enters Retail Partnership with Superdrug
    IT Award Winners Announced at MakeUp in NY
    Happi

    Latest Breaking News From Happi

    Color Street Launches ‘Don’t Be Afraid’ Halloween Nail Art Collection
    Dental Care Trends and SBLA Beauty's Advertising Claims Under Scrutiny
    OffCourt Debuts in Walmart Stores Nationwide
    Ink World

    Latest Breaking News From Ink World

    Cooper Watson Acquires Tower Products
    The Durst Group Awarded Eight 2023 PRINTING United Alliance Pinnacle Awards
    Weekly Recap: Wikoff Color, HP, INX VC Top This Week’s Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PRX Market debuts, Tower Products acquired and more
    Flexo Wash to exhibit at FTA Fall Technical Conference
    Recyclable, deinkable stand-up pouch wins Gold in Germany
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 23
    Anika Releases RevoMotion Reverse Shoulder Arthroplasty System
    Exactech's Activit-E Polyethylene OK'ed for Vantage Total Ankle
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HID to Showcase Future-Proof Solutions at GITEX 2023
    Weekly Recap: Mergers and Acquisitions, IEC’s IME Standards Top This Week’s Stories
    EU-Funded Collaboration Hub Aims to Mainstream Printed Electronics

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login